Gene expression testing
Ended Awarded Last action
- Contract number
- 36C24823F0025
- Awardee
-
Exact Sciences Corporation UEI NGBXEJX5GLE9
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $319,440
Award facts
- Contract value 34% obligated
-
- $321,971.46 Current, with exercised options
- $932,881.14 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Orlando, FL 32827, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$112,203 | |
| Exercise an Option | $150,196 | |
| Other Administrative Action | -$91,479 | |
| Exercise an Option | $150,196 | |
| Supplemental Agreement for work within scope | -$80,194 | |
| Supplemental Agreement for work within scope | $150,196 | |
| Original award | $152,727 |
About this award
Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, received a firm fixed-price delivery order from Veterans Integrated Service Network 8 (VISN 8) on October 1, 2022, for gene expression testing services. The delivery order, valued at $932,881.14 with an ultimate completion date of February 5, 2026, is not designated as a set-aside procurement. Services will be performed in Orlando, Florida, and the award falls under the Medical Laboratory Testing and Analysis Services (FSS-621-II) General Services Administration Federal Supply Schedule, which enables federal agencies to procure specialized medical laboratory services through an established governmentwide acquisition contract vehicle.
Exact Sciences is a leading provider of oncology diagnostic testing services to the Department of Veterans Affairs and other federal health agencies, with extensive experience delivering gene expression profiling assays, particularly its proprietary Oncotype DX technology platform. The company analyzes mRNA expression in cancer tumor tissue to assess recurrence risk and predict treatment responsiveness across multiple cancer types. This VISN 8 delivery order represents one component of Exact Sciences' substantial federal contracting presence, which includes multiple blanket purchase agreements and indefinite delivery vehicles across numerous Veterans Integrated Service Networks, the Defense Health Agency, and the Department of Defense, reflecting sustained federal demand for the company's specialized molecular diagnostic capabilities in support of veteran oncology care.
Quick answers
Who was awarded contract 36C24823F0025?
36C24823F0025 was awarded to Exact Sciences Corporation by Veterans Integrated Service Network 8 (Veterans Health Administration) on October 1, 2022.
How much is contract 36C24823F0025 worth?
The government has obligated $319,440 on 36C24823F0025. Its current value, with exercised options, is $321,971. Its potential value, with all options, is $932,881.
Is contract 36C24823F0025 an order under another contract?
Yes. 36C24823F0025 is a delivery order under V797D70053, a federal supply schedule, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 36C24823F0025 competed?
The extent of competition for 36C24823F0025 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award